Daood R, Toledano K, Markovits D, Tavor Y, et al. Switching from intravenous tocilizumab to subcutaneous administration during COVID-19 pandemic: impact on treatment efficacy and patient satisfaction. Clin Exp Rheumatol 2023;41:744-746.
PMID: 36062738